TickerFacts.

A business in context

IOVA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-01 · 0001104659-26-105101

  2. 4 · Ownership change

    Report date 2026-09-01 · 0001104659-26-105100

  3. 4 · Ownership change

    Report date 2026-09-01 · 0001104659-26-105099

  4. 4 · Ownership change

    Report date 2026-08-10 · 0001104659-26-095040

  5. 4 · Ownership change

    Report date 2026-08-06 · 0001104659-26-093482

  6. 8-K · Current report

    Report date 2026-08-06 · 0001104659-26-092145 · Items 8.01,9.01

  7. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001104659-26-091716

  8. 8-K · Current report

    Report date 2026-08-06 · 0001104659-26-091619 · Items 2.02,9.01

  9. 8-K · Current report

    Report date 2026-06-30 · 0001104659-26-080409 · Items 8.01,9.01

  10. 4 · Ownership change

    Report date 2026-06-16 · 0001104659-26-075863

  11. 4 · Ownership change

    Report date 2026-06-16 · 0001104659-26-075861

  12. 4 · Ownership change

    Report date 2026-06-16 · 0001104659-26-075858

  13. 8-K · Current report

    Report date 2026-06-04 · 0001104659-26-072408 · Items 5.07,8.01,9.01

  14. 8-K · Current report

    Report date 2026-05-07 · 0001104659-26-056782 · Items 2.02,9.01

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001104659-26-056778

  16. DEF 14A · Proxy statement

    Report date 2026-06-10 · 0001104659-26-050458

  17. 8-K · Current report

    Report date 2026-03-17 · 0001104659-26-032774 · Items 5.02

  18. 10-K · Annual report

    Report date 2025-12-31 · 0001104659-26-018899

  19. 8-K · Current report

    Report date 2026-02-24 · 0001104659-26-018837 · Items 2.02,8.01,9.01

  20. 8-K · Current report

    Report date 2026-01-09 · 0001104659-26-002323 · Items 8.01,9.01

  21. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001104659-25-107470

  22. 8-K · Current report

    Report date 2025-11-06 · 0001104659-25-107426 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2025-08-29 · 0001104659-25-085650 · Items 8.01,9.01

  24. 8-K · Current report

    Report date 2025-08-22 · 0001104659-25-081953 · Items 1.01,9.01

  25. 8-K · Current report

    Report date 2025-08-18 · 0001104659-25-080304 · Items 8.01,9.01

  26. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001558370-25-010807

  27. 8-K · Current report

    Report date 2025-08-07 · 0001104659-25-075175 · Items 2.02,5.02,9.01

  28. 8-K · Current report

    Report date 2025-07-15 · 0001104659-25-067940 · Items 5.02,8.01,9.01

  29. 8-K · Current report

    Report date 2025-06-30 · 0001104659-25-065781 · Items 5.02

  30. 8-K · Current report

    Report date 2025-06-10 · 0001104659-25-059464 · Items 5.02

  31. 8-K · Current report

    Report date 2025-06-10 · 0001104659-25-058199 · Items 5.07

  32. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001558370-25-007009

  33. 8-K · Current report

    Report date 2025-05-08 · 0001104659-25-046101 · Items 2.02,9.01

  34. DEF 14A · Proxy statement

    Report date 2025-06-10 · 0001558370-25-005702

  35. 10-K · Annual report

    Report date 2024-12-31 · 0001558370-25-001834

  36. 8-K · Current report

    Report date 2025-02-27 · 0001104659-25-018212 · Items 2.02,9.01

  37. 8-K · Current report

    Report date 2025-02-10 · 0001104659-25-010729 · Items 8.01,9.01

  38. 8-K · Current report

    Report date 2024-11-15 · 0001104659-24-121612 · Items 1.01,1.02

  39. SC 13G/A · Ownership disclosure

    0001193125-24-258737

  40. 8-K · Current report

    Report date 2024-11-07 · 0001104659-24-115444 · Items 8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 5 transaction rows5AExercise / conversion: 18 transaction rows18MTax / exercise payment: 9 transaction rows9FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

32 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-16
2026-06-18
WEISER MICHAELA · Grant / award
Acquired
Deferred Restricted Stock Unit
Derivative security
90316.00.0
2026-06-16
2026-06-18
Dukes Iain D.A · Grant / award
Acquired
Deferred Restricted Stock Unit
Derivative security
180632.00.0
2026-06-16
2026-06-18
Countouriotis AthenaA · Grant / award
Acquired
Deferred Restricted Stock Unit
Derivative security
90316.00.0
2026-06-16
2026-06-18
Maynard Ryan DA · Grant / award
Acquired
Deferred Restricted Stock Unit
Derivative security
90316.00.0
2026-06-16
2026-06-18
Puri Raj K.A · Grant / award
Acquired
Restricted Stock Units
Derivative security
15000.00.0
2026-06-05
2026-06-09
Vogt Frederick GM · Exercise / conversion
Acquired
Common Stock15625.00.0
2026-06-05
2026-06-09
Vogt Frederick GF · Tax / exercise payment
Disposed
Common Stock6638.04.23
2026-06-05
2026-06-09
Vogt Frederick GM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
15625.00.0
2026-06-05
2026-06-09
GRAF FINCKENSTEIN FRIEDRICHF · Tax / exercise payment
Disposed
Common Stock3976.04.23
2026-06-05
2026-06-09
GRAF FINCKENSTEIN FRIEDRICHM · Exercise / conversion
Acquired
Common Stock7813.00.0
2026-06-05
2026-06-09
GRAF FINCKENSTEIN FRIEDRICHM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
7813.00.0
2026-06-05
2026-06-09
Puri Raj K.M · Exercise / conversion
Acquired
Common Stock9766.00.0
2026-06-05
2026-06-09
Puri Raj K.F · Tax / exercise payment
Disposed
Common Stock3843.04.23
2026-06-05
2026-06-09
Puri Raj K.M · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
9766.00.0
2026-06-05
2026-06-09
BILINSKY IGORF · Tax / exercise payment
Disposed
Common Stock3976.04.23
2026-06-05
2026-06-09
BILINSKY IGORM · Exercise / conversion
Acquired
Common Stock7813.00.0
2026-06-05
2026-06-09
BILINSKY IGORM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
7813.00.0
2026-06-01
2026-06-03
Vogt Frederick GF · Tax / exercise payment
Disposed
Common Stock17701.03.96
2026-06-01
2026-06-03
Vogt Frederick GM · Exercise / conversion
Acquired
Common Stock41668.00.0
2026-06-01
2026-06-03
Vogt Frederick GM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
41668.00.0
2026-06-01
2026-06-03
Puri Raj K.M · Exercise / conversion
Acquired
Common Stock5469.00.0
2026-06-01
2026-06-03
Puri Raj K.F · Tax / exercise payment
Disposed
Common Stock2508.03.96
2026-06-01
2026-06-03
Puri Raj K.M · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
5469.00.0
2026-06-01
2026-06-03
GRAF FINCKENSTEIN FRIEDRICHM · Exercise / conversion
Acquired
Common Stock8790.00.0
2026-06-01
2026-06-03
GRAF FINCKENSTEIN FRIEDRICHF · Tax / exercise payment
Disposed
Common Stock4473.03.96
2026-06-01
2026-06-03
GRAF FINCKENSTEIN FRIEDRICHM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
8790.00.0
2026-06-01
2026-06-03
BILINSKY IGORF · Tax / exercise payment
Disposed
Common Stock4473.03.96
2026-06-01
2026-06-03
BILINSKY IGORM · Exercise / conversion
Acquired
Common Stock8790.00.0
2026-06-01
2026-06-03
BILINSKY IGORM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
8790.00.0
2026-05-11
2026-05-13
Kirby Daniel GordonM · Exercise / conversion
Acquired
Common Stock10000.00.0
2026-05-11
2026-05-13
Kirby Daniel GordonF · Tax / exercise payment
Disposed
Common Stock2435.03.7
2026-05-11
2026-05-13
Kirby Daniel GordonM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
10000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001425205IOVANCE BIOTHERAPEUTICS, INC.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Iovance Biotherapeutics · alias · wikidata
  • Lion Biotechnologies, Inc. · former SEC name · 2013-10-23 to 2017-06-05
  • Genesis Biopharma, Inc · former SEC name · 2010-03-19 to 2013-09-23
  • FREIGHT MANAGEMENT CORP · former SEC name · 2008-01-29 to 2010-03-08
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$164.07M$174.65M
2023-12-31$1.19M$1.30M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗